Financial reports
10-K/A
2023 FY
Annual report (amended)
14 Mar 24
10-K
2023 FY
Annual report
22 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
23 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
8 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Completion of Acquisition or Disposition of Assets
18 Mar 24
8-K
Other Events
14 Mar 24
8-K
Submission of Matters to a Vote of Security Holders
12 Mar 24
8-K
Other Events
1 Mar 24
8-K
Karuna Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides General Business Update
22 Feb 24
8-K
Departure of Directors or Certain Officers
16 Jan 24
8-K
Entry into a Material Definitive Agreement
22 Dec 23
8-K
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
22 Dec 23
8-K
Karuna Therapeutics Reports Third Quarter 2023 Financial Results and Provides General Business Updates
2 Nov 23
8-K
Karuna Therapeutics Reports Second Quarter 2023 Financial Results and Provides General Business Updates
3 Aug 23
Registration and prospectus
15-12G
Securities registration termination
28 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Mar 24
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Mar 24
25-NSE
Exchange delisting
18 Mar 24
POSASR
Automatic shelf registration (post-effective amendment)
18 Mar 24
S-3ASR
Automatic shelf registration
21 Jun 23
424B5
Prospectus supplement for primary offering
22 Mar 23
Proxies
DEFA14A
Additional proxy soliciting materials
1 Mar 24
DEFM14A
Proxy related to merger
5 Feb 24
PREM14A
Preliminary proxy related to merger
22 Jan 24
DEFA14A
Additional proxy soliciting materials
22 Dec 23
DEFA14A
Additional proxy soliciting materials
22 Dec 23
DFAN14A
Additional proxy materials by non-management
22 Dec 23
DEFA14A
Additional proxy soliciting materials
22 Dec 23
DEFA14A
Additional proxy soliciting materials
22 Dec 23
DFAN14A
Additional proxy materials by non-management
22 Dec 23
DEFA14A
Additional proxy soliciting materials
22 Dec 23
Other
EFFECT
Notice of effectiveness
21 Nov 19
CORRESP
Correspondence with SEC
18 Nov 19
CORRESP
Correspondence with SEC
18 Nov 19
UPLOAD
Letter from SEC
5 Nov 19
EFFECT
Notice of effectiveness
28 Jun 19
CERT
Certification of approval for exchange listing
26 Jun 19
CORRESP
Correspondence with SEC
25 Jun 19
CORRESP
Correspondence with SEC
25 Jun 19
SEC STAFF
SEC staff action: Order
25 Jun 19
CORRESP
Correspondence with SEC
14 Jun 19